When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging Modalities

被引:31
作者
Sundahl, Nora [1 ,2 ]
Gillessen, Silke [3 ,4 ,5 ,6 ]
Sweeney, Christopher [7 ,8 ]
Ost, Piet [1 ]
机构
[1] Ghent Univ Hosp, Dept Radiat Oncol, C Heymanslaan 10, B-9000 Ghent, Belgium
[2] Inst Canc Res, Div Radiotherapy & Imaging, London, England
[3] Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[4] Univ Svizzera Italiana, Lugano, Switzerland
[5] Univ Bern, Bern, Switzerland
[6] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
PROSTATE-CANCER; METASTASIS; THERAPY;
D O I
10.1016/j.eururo.2020.07.029
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:565 / 567
页数:3
相关论文
共 10 条
  • [1] Ali SA, 2019, ANN ONCOL, V30, P330
  • [2] Phase II randomized clinical trial of endosonography and PET/CT versus clinical assessment only for follow-up after surgery for upper gastrointestinal cancer (EUFURO study)
    Bjerring, O. S.
    Fristrup, C. W.
    Pfeiffer, P.
    Lundell, L.
    Mortensen, M. B.
    [J]. BRITISH JOURNAL OF SURGERY, 2019, 106 (13) : 1761 - 1768
  • [3] A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases
    Daza, Julian E.
    Solis, Natalie M.
    Parpia, Sameer
    Gallinger, Steven
    Moulton, Carol-Anne
    Belley-Cote, Emilie P.
    Levine, Mark N.
    Serrano, Pablo E.
    [J]. EJSO, 2019, 45 (08): : 1341 - 1348
  • [4] INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL
    DELTURCO, MR
    PALLI, D
    CARIDDI, A
    CIATTO, S
    PACINI, P
    DISTANTE, V
    AZZINI, V
    BELSANTI, V
    BARTOLUCCI, R
    DICOSTANZO, F
    BERTUSI, M
    DANESE, S
    GIARDINA, G
    DAIUTO, G
    UCCELLO, V
    DELEO, G
    PUNZO, C
    GOSSO, P
    GRISO, C
    LOCATELLI, E
    MANSUTTI, M
    SANDRI, P
    MOLINO, AM
    SCHINCAGLIA, P
    TIENGHI, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (20): : 1593 - 1597
  • [5] Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
    Hofman, Michael S.
    Lawrentschuk, Nathan
    Francis, Roslyn J.
    Tang, Colin
    Vela, Ian
    Thomas, Paul
    Rutherford, Natalie
    Martin, Jarad M.
    Frydenberg, Mark
    Shakher, Ramdave
    Wong, Lih-Ming
    Taubman, Kim
    Lee, Sze Ting
    Hsiao, Edward
    Roach, Paul
    Nottage, Michelle
    Kirkwood, Ian
    Hayne, Dickon
    Link, Emma
    Marusic, Petra
    Matera, Anetta
    Herschtal, Alan
    Iravani, Amir
    Hicks, Rodney J.
    Williams, Scott
    Murphy, Declan G.
    [J]. LANCET, 2020, 395 (10231) : 1208 - 1216
  • [6] Hope TA, 2020, J CLIN ONCOL, V38
  • [7] Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group
    Lecouvet, Frederic E.
    Oprea-Lager, Daniela E.
    Liu, Yan
    Ost, Piet
    Bidaut, Luc
    Collette, Laurence
    Deroose, Christophe M.
    Goffin, Karolien
    Herrmann, Ken
    Hoekstra, Otto S.
    Kramer, Gem
    Lievens, Yolande
    Lopci, Egesta
    Pasquier, David
    Petersen, Lars J.
    Talbot, Jean-Noel
    Zacho, Helle
    Tombal, Bertrand
    desouza, Nandita M.
    [J]. LANCET ONCOLOGY, 2018, 19 (10) : E534 - E545
  • [8] A prospective phase 2/3 multicenter study of 18F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy (OSPREY).
    Morris, Michael J.
    Carroll, Peter
    Probst, Stephan
    Pouliot, Frederic
    Saperstein, Lawrence
    Siegel, Barry A.
    Alva, Ajjai Shivaram
    Preston, Mark A.
    Patnaik, Akash
    Gorin, Michael A.
    Durack, Jeremy C.
    Nichols, Melissa
    Lin, Tess
    Strack, Thomas
    DiPippo, Vincent A.
    Jensen, Jessica Donato
    Mahmood, Syed
    Wong, Vivien
    Pienta, Kenneth J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial
    Sobhani, I.
    Itti, F.
    Luciani, A.
    Baumgaertner, I.
    Layese, R.
    Andre, T.
    Ducreux, M.
    Cornet, J. -M.
    Goujon, G.
    Aparicio, T.
    Taieb, J.
    Bachet, J. -B.
    Hemery, F.
    Retbi, A.
    Mons, M.
    Flicoteaux, R.
    Rhein, B.
    Baron, S.
    Cherrak, I.
    Rufat, P.
    Le Corvoisier, P.
    de'Angelis, N.
    Natella, P. -A.
    Maoulida, H.
    Tournigand, C.
    Zaleski, I. Durand
    Bastuji-Garin, S.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (04) : 931 - 937
  • [10] Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
    Warde, Padraig
    Mason, Malcolm
    Ding, Keyue
    Kirkbride, Peter
    Brundage, Michael
    Cowan, Richard
    Gospodarowicz, Mary
    Sanders, Karen
    Kostashuk, Edmund
    Swanson, Greg
    Barber, Jim
    Hiltz, Andrea
    Parmar, Mahesh K. B.
    Sathya, Jinka
    Anderson, John
    Hayter, Charles
    Hetherington, John
    Sydes, Matthew R.
    Parulekar, Wendy
    [J]. LANCET, 2011, 378 (9809) : 2104 - 2111